Americhem Launches EcoLube™ MD PFAS-Free Internally Lubricated Compounds for Healthcare Applications
Americhem, Inc., a globally recognized designer and manufacturer of custom color masterbatch, functional additives, engineered compounds, and performance technologies, has launched the EcoLube™ MD line of PFAS-free internally lubricated compounds specifically for medical devices and other healthcare applications.
This press release features multimedia. View the full release here:
EcoLube™ MD Pre-lubricated Engineered Compounds (Photo: Business Wire)
Building on the success of Americhem's launch of EcoLube™ in 2024, EcoLube™ MD offers significant advantages for healthcare applications. As a sustainable, non-PFAS solution, EcoLube™ MD addresses the critical need for effective wear and friction reduction. It ensures compliance with current and future regulations, demonstrates environmental stewardship, and reduces environmental impact.
EcoLube™ MD pre-lubricated engineered compounds and alloys are designed to help manufacturers reduce the wear and friction of moving plastic parts, reduce noise during use, and decrease the coefficient of friction for plastic-on-plastic and plastic-on-metal applications, all without the use of PFAS components. End-use applications can include minimally invasive surgical devices, syringe pumps, prosthetics, surgical robots, and more.
Matt Miklos, Vice President/General Manager of Americhem's engineered compounds division, noted that healthcare OEMs are increasingly concerned about sustainability and ensuring that new products meet current and future regulations.
'With regulations around the world potentially restricting or banning the use of PFAS and PTFE, healthcare OEMs are challenged with finding alternatives that can match their self-lubricating performance,' said Miklos. 'Our new PFAS-free EcoLube™ MD line showcases Americhem's dedication to innovation, meeting their unique needs and helping them stay ahead in their respective markets.'
Enhancing Medical Devices with Rigorous Material Performance and Compliance
Linda Boyett, Vice President of Global Technology & Innovation at Americhem, said Ecolube™ MD has undergone testing for performance and biocompatibility. Internal testing has indicated similar performance to the more traditional internal lubricants and wear resistant additives in most cases. Ecolube™ MD has undergone ISO10993 –5 testing for biocompatibility as part of the global medical compliance certifications.
'ISO10993 – 5 testing for biocompatibility is an important global medical compliance certification, and we're proud that EcoLube™ MD is a proven solution that supports sustainability and performance for the healthcare industry,' said Boyett.
EcoLube™ Family of Lubricants
EcoLube™ shatters the limitations of conventional lubrication, ushering in a new era of embedded performance. This revolutionary technology integrates specially designed functional additives directly into the material, providing long-lasting lubrication from within. A variety of functional additives cater to specific applications, resulting in a versatile EcoLube™ product line capable of tackling a wide range of lubrication challenges.
Solid state, non-migrating lubricants that stand up to extreme pressures, reducing frictional wear and 'slip-stick' behavior in nylon bearings.
Multifunctional, migrating, boundary lubricants reduce the coefficient of friction and wear rate by providing immediate lubrication at start-up and high speeds.
Non-traditional formulations offer shear reinforcement and abrasion resistance between moving, mating parts.
Low friction, non-migratory additives are designed to offset PTFE in various applications and thermoplastics.
Ecolube™ MD biocompatibility testing and compliance with the medical certifications are coupled with AEC's stringent Process Change Management commitments and locked formulation promise make it an easy choice for a variety of medical applications.
A Wide Range of Base Resins
Americhem has formulated EcoLube™ compounds in a wide variety of base resins, including ABS, PBT, PCABS, PC, PEI, PPE, PPS, PE, PP, PSU, PPSU, POM, PEEK, PPA, PA, and TPU.
'We pride ourselves on our ability to customize products to fit end-market performance, conversion processes, color, and aesthetic requirements. By working closely with our customers, we shape specifications and new technologies to meet their unique needs and sustainability objectives,' added Miklos.
About Americhem
Americhem is an innovative, technology-driven leader in the global polymer industry. Its foundation is built around delivering Performance, Solutions and Trust through close collaboration with customers. All of the company's products are backed by complete technical support that ensures quality, reliability, and value. Americhem operates 10 manufacturing plants and maintains sales offices throughout the world.
SOURCE: Americhem, Inc.
Copyright Business Wire 2025.
PUB: 01/29/2025 09:30 AM/DISC: 01/29/2025 09:31 AM
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Business Wire
14 minutes ago
- Business Wire
ExchangeRight Secures 50 Lease Renewals and Sustains 100% Rent Collection for its Essential Income REIT
PASADENA, Calif.--(BUSINESS WIRE)--ExchangeRight has announced that through Q2 2025 the company maintained 100% rent collections and executed 50 lease renewals across the company's entire net lease platform, including all properties in the Essential Income REIT. This strong asset management resulted in a net lease occupancy rate of 99.86% as of June 30, 2025, among the highest in the net lease sector. Through Q2 2025, ExchangeRight maintained 100% rent collections and executed 50 lease renewals across the company's entire net lease platform, including all properties in ExchangeRight's Essential Income REIT. Share ExchangeRight's Asset Management Update as of June 30, 2025 Leasing Performance Highlights (2023 – Q2 2025) 50 lease renewals executed with 11 national tenants operating essential businesses, including industry-leading retailers and service providers Average lease extension of 64 months, reinforcing long-term tenant commitments and supporting consistent cash flow to investors 6.15% weighted average rent increases secured on renewed leases, enhancing overall rental income and portfolio performance Net Lease Platform Occupancy 99.86% occupancy rate for ExchangeRight's net-leased assets under management as of June 30, 2025, reflecting one of the highest occupancy rates in the net lease sector 25:1 ratio of lease renewals and re-leases to vacancies, demonstrating strong tenant retention and successful re-leasing strategies Only 17 leases across the Net Lease Platform (0.60% of total platform rents) with expirations in the next 12 months, minimizing near-term rollover risk Past performance does not guarantee future results. 'Our disciplined Asset Management and Leasing teams continue to deliver strong results on behalf of investors, supporting ExchangeRight's reputation for proactive and investor-centric operational management,' said Tim Williams, director of asset management. 'These results benefit ExchangeRight's investors by supporting stable monthly distributions to empower investors to be secure, free, and generous.' 'As we execute our aggregation strategy and scale our REIT platform, each renewal strengthens long-term income potential for investors,' said Joshua Ungerecht, a managing partner at ExchangeRight. 'Our focus remains on stewarding investor capital faithfully by prioritizing operational excellence, creditworthy tenants, and recession-resilient assets throughout all market cycles.' About ExchangeRight ExchangeRight and its affiliates' vertically integrated platform features more than $6.6 billion in assets under management that are diversified across over 1,300 properties, and 26 million square feet throughout 47 states, as of July 31, 2025. ExchangeRight pursues its passion to empower people to be secure, free, and generous through its Essential Income REIT and 1031 DST portfolios that target secure capital, stable income, and strategic exits, all of which have historically met or exceeded investor projections since ExchangeRight's inception. On behalf of investors nationwide, the company structures and manages net-leased portfolios of assets backed primarily by investment-grade corporations that have successfully operated in the necessity-based retail and healthcare industries. Past performance does not guarantee future results. Please visit for more information.
Yahoo
30 minutes ago
- Yahoo
Is Most-Watched Stock JD.com, Inc. (JD) Worth Betting on Now?
Inc. (JD) is one of the stocks most watched by visitors lately. So, it might be a good idea to review some of the factors that might affect the near-term performance of the stock. Over the past month, shares of this company have returned -4.9%, compared to the Zacks S&P 500 composite's +2.5% change. During this period, the Zacks Internet - Commerce industry, which falls in, has gained 2.3%. The key question now is: What could be the stock's future direction? Although media reports or rumors about a significant change in a company's business prospects usually cause its stock to trend and lead to an immediate price change, there are always certain fundamental factors that ultimately drive the buy-and-hold decision. Revisions to Earnings Estimates Here at Zacks, we prioritize appraising the change in the projection of a company's future earnings over anything else. That's because we believe the present value of its future stream of earnings is what determines the fair value for its stock. Our analysis is essentially based on how sell-side analysts covering the stock are revising their earnings estimates to take the latest business trends into account. When earnings estimates for a company go up, the fair value for its stock goes up as well. And when a stock's fair value is higher than its current market price, investors tend to buy the stock, resulting in its price moving upward. Because of this, empirical studies indicate a strong correlation between trends in earnings estimate revisions and short-term stock price movements. is expected to post earnings of $0.40 per share for the current quarter, representing a year-over-year change of -67.7%. Over the last 30 days, the Zacks Consensus Estimate remained unchanged. For the current fiscal year, the consensus earnings estimate of $2.49 points to a change of -41.6% from the prior year. Over the last 30 days, this estimate has changed +0.3%. For the next fiscal year, the consensus earnings estimate of $3.61 indicates a change of +45.2% from what is expected to report a year ago. Over the past month, the estimate has changed +0.3%. With an impressive externally audited track record, our proprietary stock rating tool -- the Zacks Rank -- is a more conclusive indicator of a stock's near-term price performance, as it effectively harnesses the power of earnings estimate revisions. The size of the recent change in the consensus estimate, along with three other factors related to earnings estimates, has resulted in a Zacks Rank #5 (Strong Sell) for The chart below shows the evolution of the company's forward 12-month consensus EPS estimate: 12 Month EPS Revenue Growth Forecast Even though a company's earnings growth is arguably the best indicator of its financial health, nothing much happens if it cannot raise its revenues. It's almost impossible for a company to grow its earnings without growing its revenue for long periods. Therefore, knowing a company's potential revenue growth is crucial. In the case of the consensus sales estimate of $40.08 billion for the current quarter points to a year-over-year change of +8%. The $183.33 billion and $192.78 billion estimates for the current and next fiscal years indicate changes of +14% and +5.2%, respectively. Last Reported Results and Surprise History reported revenues of $49.79 billion in the last reported quarter, representing a year-over-year change of +24.2%. EPS of $0.69 for the same period compares with $1.29 a year ago. Compared to the Zacks Consensus Estimate of $46.93 billion, the reported revenues represent a surprise of +6.1%. The EPS surprise was +38%. The company beat consensus EPS estimates in each of the trailing four quarters. The company topped consensus revenue estimates each time over this period. Valuation No investment decision can be efficient without considering a stock's valuation. Whether a stock's current price rightly reflects the intrinsic value of the underlying business and the company's growth prospects is an essential determinant of its future price performance. While comparing the current values of a company's valuation multiples, such as price-to-earnings (P/E), price-to-sales (P/S), and price-to-cash flow (P/CF), with its own historical values helps determine whether its stock is fairly valued, overvalued, or undervalued, comparing the company relative to its peers on these parameters gives a good sense of the reasonability of the stock's price. The Zacks Value Style Score (part of the Zacks Style Scores system), which pays close attention to both traditional and unconventional valuation metrics to grade stocks from A to F (an A is better than a B; a B is better than a C; and so on), is pretty helpful in identifying whether a stock is overvalued, rightly valued, or temporarily undervalued. is graded C on this front, indicating that it is trading at par with its peers. Click here to see the values of some of the valuation metrics that have driven this grade. Conclusion The facts discussed here and much other information on might help determine whether or not it's worthwhile paying attention to the market buzz about However, its Zacks Rank #5 does suggest that it may underperform the broader market in the near term. Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Inc. (JD) : Free Stock Analysis Report This article originally published on Zacks Investment Research ( Zacks Investment Research Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
43 minutes ago
- Yahoo
AM Best's 2026 Student Challenge Calls on Participants to Solve Insurance Risks; Prize Total of $10,000 Announced
OLDWICK, N.J., August 19, 2025--(BUSINESS WIRE)--AM Best's 2026 Student Challenge, which gives undergraduate and graduate-level students the opportunity to develop and showcase innovative solutions for risk management and insurance, has added a prize component. Now open for submissions, the Student Challenge calls for students to generate ideas in one of three areas: Monitoring AI (Artificial Intelligence) Risk and Claims; Expanding Flood Coverage; and Meeting the Needs of the Gig Economy. Participants in the Student Challenge will be vying for: First prize of $5,000, second prize of $3,000 and third prize of $2,000 A donation of $5,000 to the school of the first-place team An interview with insurance industry media network AM Best TV A feature article in Best's Review magazine Recognition on AM Best's social media channels An academic medal and trophy Students can read further information in AM Best's 2026 Student Challenge Handbook. First-round submissions are due October 6, 2025, with final-round submissions due January 22, 2026. Winners will be notified April 9, 2026. Student submissions will be reviewed by professionals in AM Best Rating Services, then narrowed down to three finalists. Submissions will be judged based on degree of innovation, feasibility, impact, implementation and more. "AM Best's 2026 Student Challenge enables students to gain first-hand experience in insurance and risk management," said Lee McDonald, senior vice president, AM Best - Information Services. "It serves as a catalyst for students to work collaboratively with risk management faculty at their schools, build teams of fellow students and bring their ideas to life. It also provides feedback from AM Best experts and expands students' resumes with an insurance-specific project." McDonald added: "Our company's founder, Alfred M. Best, emphasized the importance of 'the ingenuity with which at all times the new needs of the public have been met.' That's the essence of insurance: using innovation to solve risk challenges as the world shifts. AM Best welcomes the opportunity to collaborate with the rising generation of professionals to apply their ingenuity and lead the insurance industry toward the future." In addition to the 2026 Student Challenge, AM Best also offers internships and an Analytical Development Program as ongoing initiatives to support the development of new talent in the insurance industry. AM Best is a global credit rating agency, news publisher and data analytics provider specializing in the insurance industry. Headquartered in the United States, the company does business in over 100 countries with regional offices in London, Amsterdam, Dubai, Hong Kong, Singapore and Mexico City. For more information, visit Copyright © 2025 by A.M. Best Company, Inc. and/or its affiliates. ALL RIGHTS RESERVED. View source version on Contacts Lee McDonald Senior Vice President, Publication & News Services +1 908 882
